CRISPR metabolic screen identifies ATM and KEAP1 as targetable genetic vulnerabilities in solid tumors

Haojian Li(National Cancer Institute), Urbain Weyemi(National Institutes of Health)
bioRxiv (Cold Spring Harbor Laboratory)
May 4, 2022
Cited by 2


Related Papers